Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01788748
Other study ID # PRB-E2VER02
Secondary ID 2012-A01427-3612
Status Completed
Phase N/A
First received February 5, 2013
Last updated December 30, 2013
Start date February 2013
Est. completion date November 2013

Study information

Verified date December 2013
Source Candela France
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

This is an interventional open prospective randomized study, done in two sites.

The main purpose of this study is to evaluate the efficacy of the combination of bipolar radiofrequency potentiated by an infrared light followed by fractional bipolar radiofrequency for the treatment of striae on the abdomen.

In order to have a more complete and accurate study, each technology will also be evaluated separately. This will allow the comparison of the effect of each treatment, in monotherapy or combined.


Description:

Stria is a very common condition that affects psychologically and aesthetically a lot of patients. It is a linear atrophic scar. So, to be treated, it needs to have both a superficial and a deep impact.

Several technologies have already been tested for this indication, but none of them have been proved at the same time effective and without a high risk of side effects for all skin types. As radiofrequency is an electrical current, it is not absorbed and does not see melanin. So it can be used on all skin types.

When using fractional bipolar radiofrequency, the current goes from small electrodes to return electrodes. Around the small electrodes appear some epidermal ablation, coagulation and deeper thermal damage. This means it has a superficial and a deep effect.

Using infrared combined with bipolar radiofrequency allows the infrared to pre-heat the skin so as to help the radiofrequency to go deeper in the skin more easily. This has a deep effect in the dermis.

In this study, both technologies will be used. At least 20 patients will be treated in two different sites.

The abdomen of each patient will be divided in four quadrants around the navel. Each quadrant will receive a total of three treatments one month apart:

- One quadrant will be the control (no treatment will be done)

- One quadrant will receive each time only bipolar radiofrequency potentiated by infrared

- One quadrant will receive each time only fractional bipolar radiofrequency

- One quadrant will receive each time first bipolar radiofrequency potentiated by infrared, followed in the same session by fractional bipolar radiofrequency.

The choice of the treatment for each area will be randomized at the enrollment of the patient in the study.

There will be two follow-up sessions 3 and 6 months after the last treatment.

The evaluation will be done mainly by 3D acquisitions. This will allow measuring the length, width and depth of the striae and evaluating their evolution after the treatment.

Some patients, if they agree, will also have in vivo confocal microscopy before the first treatment and 6 months after the last one. This will give more information on the collagen and elastin changes.

Four patients, who accept it, will have biopsies performed before the first treatment and 6 months after the last one to also show the evolution of the skin structure.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date November 2013
Est. primary completion date November 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male and female subject over 18 years old, with striae on all the abdomen (white or red)

- Consent form signed by subjects

- Affiliation to social security

Exclusion Criteria:

- Electrical implants (pace maker, defibrillator) or superficial metallic implants (gold thread…)

- Pregnant woman

- Woman who can procreate without using an effective birth control

- Deficient immune system due to immunosuppressive diseases such as AIDS or HIV, or use of immunosuppressive drugs,

- Stretch marks resulting from treatment with steroids,

- Treatment with oral retinoids ongoing or stopped less than a year ago, or photosensitizing ongoing or stopped less than 3 months ago

- History of diseases stimulated by heat (recurrent herpes) on the treatment area

- Procedure less than 6 months ago performed on the treatment area,

- History of keloid scarring or difficulty in healing,

- History of allergy to xylocaine (for subjects who will have biopsy)

- Dermatological disorder requiring systemic therapy or local therapy in the area under study,

- Systemic disease in evolution (cancer or history of cancer, heart disease, uncontrolled diabetes, pain syndrome, history of neuropathy)

- Problem of coagulation and / or anticoagulant therapy,

- Vascular lesions or tattoos on the treatment area,

- Vulnerable Person: minor, under protection, deprived of liberty.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
bipolar radiofrequency and infrared

fractional bipolar radiofrequency


Locations

Country Name City State
France Aesthetics Bordeaux
France CHU Archet II, Service de Dermatologie Nice

Sponsors (1)

Lead Sponsor Collaborator
Candela France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of striae volume The stretch marks in each area will be evaluated with a 3D camera (Antera 3D, Miravex). This will give access to the length, width and depth of each stria. Those measurements will then be compared so as to evaluate each technology. before the first treatment, 3 and 6 months after the last treatment. Months 0, 5 and 8 No
Secondary Observation of the skin structure changes with in vivo confocal microscopy In vivo confocal microscopy acquisitions will be done on all subjects who agree to do so. It is a non-invasive imaging procedure that shows the different structures of the skin (such as collagen fibers and elastin). This will allow us to assess the effect of both technologies, used in monotherapy or combined, on those structures. 5 months No
Secondary Observation of the skin structure changes with in vivo confocal microscopy In vivo confocal microscopy acquisitions will be done on all subjects who agree to do so. It is a non-invasive imaging procedure that shows the different structures of the skin (such as collagen fibers and elastin). This will allow us to assess the effect of both technologies, used in monotherapy or combined, on those structures. 8 months No
Secondary Observation of the skin structure changes by histology For four patients, who previously agreed to do so, 3 biopsies will be done (one on each quadrant that will receive a treatment) before any treatment and at the 6 month follow-up session. They will be analyzed in the anatomopathology laboratory of the Archet II hospital. It will show the entire dermal and epidermal evolution after each type of treatment. 8 months No
Secondary Pain assessment Pain will be assessed with an analogical visual scale. 1 month No
Secondary Pain assessment Pain will be assessed with an analogical visual scale. 2 months No
Secondary Global satisfaction The global satisfaction of both the subject and the investigator will be assessed with an analogical visual scale. 1 month No
Secondary Global satisfaction The global satisfaction of both the subject and the investigator will be assessed with an analogical visual scale. 2 months No
Secondary Double blinded pictures observation Standardized pictures will be taken at the beginning of each session. Two external doctors will evaluate each picture on a Physician Global Assessment scale, without knowing to which session or to which subject it corresponds. 5 months No
Secondary Double blinded pictures observation Standardized pictures will be taken at the beginning of each session. Two external doctors will evaluate each picture on a Physician Global Assessment scale, without knowing to which session or to which subject it corresponds. 8 months No
Secondary global satisfaction The global satisfaction of both the subject and the investigator will be assessed with an analogical visual scale. 5 months No
Secondary Global satisfaction The global satisfaction of both the subject and the investigator will be assessed with an analogical visual scale. 8 months No
Secondary Pain assessment Pain will be assessed with an analogical visual scale. first day No
See also
  Status Clinical Trial Phase
Completed NCT01027793 - Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks Phase 4
Completed NCT01810484 - Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment N/A
Completed NCT01745211 - 755nm Alex Laser for Treatment of Stretch Marks N/A
Completed NCT01796626 - Clinical Evaluation of M22 ResurFX 1565nm Module N/A